|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 114.70 USD | -0.77% |
|
-4.99% | +8.68% |
| 11-27 | European Equities Traded in the US as American Depositary Edge Higher in Wednesday Trading | MT |
| 11-27 | BIONTECH : Deutsche Bank reiterates its Buy rating | ZD |
Days
Hours
Minutes
Seconds
-40%
on all our subscriptions*
Exceptional extension!
Enjoy this offer
* See conditions on site
| Capitalization | 26.36B 27.71B 24.56B 21.89B 38.98B 2,347B 42.8B 305B 113B 963B 104B 102B 4,143B | P/E ratio 2024 * |
-36.8x | P/E ratio 2025 * | -32.3x |
|---|---|---|---|---|---|
| Enterprise value | 13.41B 14.09B 12.49B 11.13B 19.83B 1,194B 21.77B 155B 57.57B 490B 52.96B 51.77B 2,107B | EV / Sales 2024 * |
5.14x | EV / Sales 2025 * | 5.46x |
| Free-Float |
86.48% | Yield 2024 * |
-
| Yield 2025 * | - |
More valuation ratios
* Estimated data
More news
Last Transcript: BioNTech SE
More recommendations
More press releases
More news
| 1 day | -1.37% | ||
| 1 week | -2.49% | ||
| Current month | -2.37% | ||
| 1 month | +3.69% | ||
| 3 months | +31.35% | ||
| 6 months | +12.37% | ||
| Current year | +9.52% |
1 week
115.30
120.48
1 month
94.31121.80
Current year
76.53131.49
1 year
76.53131.49
3 years
76.53321.86
5 years
21.35464.00
10 years
12.53464.00
| Director | Title | Age | Since |
|---|---|---|---|
Özlem Türeci
CTO | Chief Tech/Sci/R&D Officer | 57 | 31/12/2017 |
Ugur Sahin
CEO | Chief Executive Officer | 59 | 01/06/2008 |
Jens Holstein
DFI | Director of Finance/CFO | 60 | 30/06/2021 |
| Manager | Title | Age | Since |
|---|---|---|---|
Helmut Jeggle
CHM | Chairman | 54 | 01/06/2008 |
| Director/Board Member | 67 | 01/06/2008 | |
| Director/Board Member | 63 | 31/12/2017 |
| Name | Weight | AuM | 1st Jan change | Investor Rating |
|---|---|---|---|---|
| 2.92% | 1 M€ | -.--% | - | |
| 2.63% | 0 M€ | 0.00% | - |
| Change | 5d. change | 1-year change | 3-years change | Capi. ($) | ||
|---|---|---|---|---|---|---|
| -1.37% | -2.49% | +16.29% | -66.40% | 27.71B | ||
| -1.88% | -2.16% | +30.13% | +124.21% | 118B | ||
| -1.68% | -0.46% | -8.01% | +18.01% | 80.65B | ||
| -0.27% | +2.01% | +40.95% | +131.12% | 37.33B | ||
| +0.13% | +7.24% | +9.88% | -34.42% | 21.89B | ||
| +2.15% | +6.78% | -36.96% | -63.10% | 20.55B | ||
| -1.29% | +5.08% | -29.03% | -37.67% | 13.7B | ||
| -3.89% | -7.45% | +734.27% | +255.40% | 13.1B | ||
| +0.01% | -4.29% | +173.11% | +179.76% | 12.96B | ||
| -0.36% | -1.93% | +7.10% | +57.43% | 12.7B | ||
| Average | -0.84% | +0.25% | +93.77% | +56.43% | 35.83B | |
| Weighted average by Cap. | -1.20% | +0.11% | +44.36% | +64.09% |
| 2024 * | 2025 * | |
|---|---|---|
| Net sales | 2.61B 2.74B 2.43B 2.17B 3.86B 233B 4.24B 30.24B 11.21B 95.34B 10.31B 10.08B 410B | 2.58B 2.71B 2.4B 2.14B 3.82B 230B 4.19B 29.88B 11.08B 94.21B 10.19B 9.96B 406B |
| Net income | -765M -804M -712M -635M -1.13B -68.1B -1.24B -8.86B -3.28B -27.92B -3.02B -2.95B -120B | -813M -855M -758M -675M -1.2B -72.43B -1.32B -9.42B -3.49B -29.7B -3.21B -3.14B -128B |
| Net Debt | -12.95B -13.62B -12.07B -10.76B -19.16B -1,154B -21.03B -150B -55.63B -473B -51.17B -50.02B -2,036B | -12.27B -12.9B -11.43B -10.19B -18.15B -1,093B -19.93B -142B -52.71B -448B -48.48B -47.4B -1,929B |
More financial data
* Estimated data
Employees
6,133
Calendar
09/12/2024
- San Antonio Breast Cancer Symposium
| Date | Price | Change | Volume |
|---|---|---|---|
| 04/12/24 | 114.70 $ | -0.77% | 417,358 |
| 03/12/24 | 115.59 $ | -1.37% | 613,052 |
| 02/12/24 | 117.20 $ | -1.01% | 599,019 |
| 29/11/24 | 118.39 $ | -1.93% | 518,891 |
| 27/11/24 | 120.72 $ | +1.84% | 604,796 |
Delayed Quote Nasdaq, December 03, 2024 at 09:00 pm
More quotes
Sell
Buy
Mean consensus
BUY
Number of Analysts
19
Last Close Price
109.96EUR
Average target price
129.45EUR
Spread / Average Target
+17.72%
Quarterly revenue - Rate of surprise
- Stock Market
- Equities
- BNTX Stock
MarketScreener is also available in this country: United States.
Switch edition
Stay in the current country edition